Craig Hofmeister
Physician · Emory University School of Medicine
Credentials: · · · · ·
History
Research
Initial genome sequencing and analysis of multiple myeloma
Nature · 2011 · 1,207 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
Blood · 2010 · 686 citations
47 papers
40 papers
34 papers
- SD
34 papers
- YE
34 papers
33 papers
28 papers
27 papers · 3 as a fellow
Grants
- 2016–2023
Reolysin-Based Combination Therapy in Relapsed Multiple Myeloma
National Cancer Institute · R01
Contact PI · $2.7M · Beckman Research Institute/City of Hope
- 2016–2022
Overcoming IMiD Resistance in Myeloma
National Cancer Institute · R01
Contact PI · $2.6M · Ohio State University
- 2011–2014
Phase 1 of AR-42 in Relapsed CLL, Lymphoma, Myeloma
National Cancer Institute · R21
Contact PI · $577.3K · Ohio State University
Clinical trials
- 2021–2027
Personalized Autologous Transplant for Multiple Myeloma
Principal investigator · Recruiting · Phase 1
Emory University
- 2021–2028
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
Principal investigator · Active not recruiting · Phase 1
Emory University
- 2019–2022
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Principal investigator · Completed · Phase 4
Emory University
- 2018–2022
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1
Emory University